Clinical (phospho)-proteomics for precision medicine
September 12 @ 16:00 – 17:00 CEST
Clinical (phospho)proteomics for precision medicine
Welcome to a lecture by Professor Connie R Jimenez, Amsterdam University Medical Center, Netherlands
- 16.00-17.00 Monday September 12
- Air & Fire (Gamma 2) or
- via zoom https://kth-se.zoom.us/s/69393882589
Connie Jimenez is Professor of Translational OncoProteomics at the Amsterdam University Medical Center in The Netherlands, where she is heading the OncoProteomics Laboratory as well as the Proteomics Core Facility.
She is a molecular/cellular biologist with focus on the global analysis of the functional building blocks of life, i.e., the proteins which activity and functions are highly deranged in disease. Her lab’s mission is to apply innovative mass spectrometry-based proteomics and data analysis to obtain systems biology insights into disease and to improve early diagnostics and treatment, most notably of cancer and neurodegenerative disease.
During her graduate studies at the Vrije Universiteit in Amsterdam (1993-1997), she pioneered single cell peptide profiling by mass spectrometry. During her post-doc in the Burlingame lab at UCSF, San Francisco ((1997-1999), she applied proteomics to study neuron differentiation. In 2006, she founded the OncoProteomics Laboratory (www.oncoproteomics.nl) with a start-up grant of the Cancer Center Amsterdam.
To date, Dr. Jimenez (co)authored > 200 scientific peer reviewed articles. Underscoring her (inter)national esteem, she founded the Netherlands Proteomics Platform in 2000 and is member of its steering board; she is general council member of the European Proteomics Association since 2005 and elected Vice-President since 2021; she is member of the steering committee of the Cancer HPP project of the Human Proteome Organisation. Finally, she is editorial board member of several leading proteomics journals.
This keynote lecture is part of the FEBS Advanced Course – Exploring the Human Proteome